{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:11:11Z","timestamp":1790770271826,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.pnpbp.2021.110250","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T11:41:47Z","timestamp":1611142907000},"page":"110250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the \u201creal-life\u201d"],"prefix":"10.1016","volume":"109","author":[{"given":"Palmiero","family":"Monteleone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giammarco","family":"Cascino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Maria","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Collantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Corrivetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Dell\u2019Osso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Frascarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Maria","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Montemagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Oldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Roncone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Siracusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Zeppegno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Galderisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2021.110250_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-3223(97)00190-X","article-title":"Multiple fixed doses of \u201cSeroquel\u201d (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group","volume":"42","author":"Arvanitis","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2007.05.022","article-title":"Predicting schizophrenia patients\u2019 real-world behavior with specific neuropsychological and functional capacity measures","volume":"63","author":"Bowie","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S0033291703008900","article-title":"Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs","volume":"34","author":"Br\u00e9bion","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0025","first-page":"12","article-title":"Movement disorders associated with atypical antipsychotic drugs","volume":"63","author":"Caroff","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0030","first-page":"55","article-title":"The relationship of pharmacology to side effects","volume":"58","author":"Casey","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.psychres.2009.03.035","article-title":"Impaired facial emotion perception in schizophrenia: a meta-analysis","volume":"178","author":"Chan","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/biomet\/asn034","article-title":"Extended Bayesian information criteria for model selection with large model spaces","volume":"95","author":"Chen","year":"2008","journal-title":"Biometrika"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0045","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/schbul\/sbt125","article-title":"Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study","volume":"40","author":"Cuesta","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0050","doi-asserted-by":"crossref","first-page":"656370","DOI":"10.1155\/2014\/656370","article-title":"Second-generation antipsychotics and extrapyramidal adverse effects","volume":"2014","author":"Divac","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0055","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/mds.23814","article-title":"The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson\u2019s disease","volume":"26","author":"Domellof","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1037\/met0000167","article-title":"A tutorial on regularized partial correlation networks","volume":"23","author":"Epskamp","year":"2018","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3758\/s13428-017-0862-1","article-title":"Estimating psychological networks and their accuracy: a tutorial paper","volume":"50","author":"Epskamp","year":"2018","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.schres.2014.11.018","article-title":"Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia","volume":"161","author":"Fervaha","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neubiorev.2010.07.001","article-title":"The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis","volume":"35","author":"Fett","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0080","author":"Friedman"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/wps.20167","article-title":"The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia","volume":"13","author":"Galderisi","year":"2014","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0090","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10401230209147398","article-title":"Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria","volume":"14","author":"Gerlach","year":"2002","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0447.1993.tb03366.x","article-title":"The St. Hans rating scale for extrapyramidal syndromes: reliability and validity","volume":"87","author":"Gerlach","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0105","first-page":"16","article-title":"Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality","volume":"61","author":"Glazer","year":"2000","journal-title":"J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0110","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/schbul\/sbi049","article-title":"Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference","volume":"31","author":"Green","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/wps.20624","article-title":"Nonsocial and social cognition in schizophrenia: current evidence and future directions","volume":"18","author":"Green","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0125","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia. Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/7854_2010_42","article-title":"Neurocognition in schizophrenia","volume":"4","author":"Kalkstein","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0447.1996.tb05944.x","article-title":"Minimizing the non-extrapyramidal side-effects of antipsychotics","volume":"94","author":"Keks","year":"1996","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1176\/appi.ajp.2007.07010043","article-title":"The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization","volume":"165","author":"Kern","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1037\/0021-843X.102.2.312","article-title":"Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance?","volume":"102","author":"Kerr","year":"1993","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0924-9338(99)80722-6","article-title":"Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia","volume":"14","author":"Krausz","year":"1999","journal-title":"Eur Psychiatry."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0160","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2021.110250_bb0165","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0170","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.schres.2006.07.024","article-title":"Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships?","volume":"89","author":"McClure","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0180","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1080\/09638280600646185","article-title":"Reliability and validity of The Awareness of Social Inference Test (TASIT): a clinical test of social perception","volume":"28","author":"McDonald","year":"2006","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brat.2016.06.006","article-title":"Can network analysis transform psychopathology?","volume":"86","author":"McNally","year":"2016","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.schres.2005.07.034","article-title":"Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial","volume":"80","author":"Miller","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1176\/appi.ajp.161.1.116","article-title":"Association of anticholinergic load with impairment of complex attention and memory in schizophrenia","volume":"161","author":"Minzenberg","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0200","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12246","article-title":"Prevalence of and risk factors for extrapyramidal side effects of antipsychotics: results from the national FACE-SZ cohort","volume":"80","author":"Misdrahi","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eurpsy.2015.01.014","article-title":"The Brief Negative Symptom Scale (BNSS): independent validation in a large sample of Italian patients with schizophrenia","volume":"30","author":"Mucci","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0210","first-page":"1","article-title":"Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives","volume":"11","author":"Mucci","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2004.09.007","article-title":"Identification of separable cognitive factors in schizophrenia","volume":"72","author":"Nuechterlein","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0225","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0006-3223(98)00167-X","article-title":"Extrapyramidal symptoms and neuropsychological deficits in schizophrenia","volume":"45","author":"Palmer","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0230","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1176\/appi.ajp.158.8.1276","article-title":"Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms","volume":"158","author":"Pantelis","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0235","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/schbul\/sbn014","article-title":"Social cognition in schizophrenia: an overview","volume":"34","author":"Penn","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00406-014-0511-y","article-title":"Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders","volume":"265","author":"Potvin","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0245","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1017\/S0033291716001100","article-title":"Social cognition in people with schizophrenia: a cluster-analytic approach","volume":"46","author":"Rocca","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","article-title":"Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons","volume":"38","author":"Rummel-Kluge","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0255","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.euroneuro.2014.07.001","article-title":"Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST","volume":"24","author":"Rybakowski","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0260","article-title":"Intermittent drug techniques for schizophrenia","volume":"20","author":"Sampson","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0265","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/schbul\/sbs080","article-title":"Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence","volume":"39","author":"Savla","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0270","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2012.10.012","article-title":"Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale","volume":"142","author":"Strauss","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0280","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1440-1819.2012.02390.x","article-title":"Clinical correlates associated with cognitive dysfunction in people with schizophrenia","volume":"66","author":"Tanaka","year":"2012","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.schres.2009.03.035","article-title":"Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis","volume":"113","author":"Ventura","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/brcg.1993.1044","article-title":"Cognitive dysfunction in schizophrenia: organic vulnerability factor or statemarker for tardive dyskinesia?","volume":"23","author":"Waddington","year":"1993","journal-title":"Brain Cogn."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0295","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","article-title":"Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia","volume":"137","author":"Wallwork","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110250_bb0300","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2013.06.013","article-title":"Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia","volume":"46","author":"Wu","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110250_bb0305","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.clpt.6100069","article-title":"Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study","volume":"81","author":"Yang","year":"2007","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:55:50Z","timestamp":1759521350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":61,"alternative-id":["S0278584621000099"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110250","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the \u201creal-life\u201d","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110250"}}